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High Dose IL-2 Among Available Melanoma Treatments

High Dose IL-2 Among Available
Melanoma Treatments
Although melanoma accounts for less than 2 percent of all skin
cancer cases, it accounts for the vast majority of skin cancer
deaths.1 “Fortunately, at Lehigh Valley Health Network (LVHN),
80 percent of melanoma patients present in stage 1 or 2, for
which surgery alone is curative,” says LVHN surgical oncologist
Rohit Sharma, MD, with LVPG Surgical Oncology.

Rohit Sharma, MD
Surgical oncology
Watch a video to learn more
about him.

Also encouraging is how treatment for metastatic melanoma
has undergone a drastic change. It’s now focused on using
immunotherapy to combat cancer cells. “Over the last 10 years,
we’ve developed a very effective high-dose interleukin-2 (IL-2)
program,” says LVHN hematologist oncologist Suresh Nair, MD,
senior medical director of research and academics for LVHN’s
Cancer Center. Lehigh Valley Hospital (LVH) is one of only a
small number of specialized IL-2 centers nationwide.

A proven cure
High-dose IL-2, which increases the number of T cells that can
attack melanoma cells, is the only proven cure for stage 4
melanoma. “We’ve treated 70 patients with high-dose IL-2, and
seven patients are completely disease free one to eight years
out,” Nair says. The national cure rate is 6 percent.2
Patients often are referred to LVH from cancer centers in
Philadelphia and throughout the state. Patients receive up to six
courses of treatment by trained IL-2 nurses in a medicalsurgical room with telemetry on the oncology floor. As a result
of this specialized care, the average hospital stay is just three to
four days, creating cost-effective treatment.
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Suresh Nair, MD
Hematology oncology
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The program’s safety record also is among the nation’s best.
“Out of 70 patients, we’ve had zero PICC line infections and
zero mortality,” Nair says. “The national average for PICC line
infections is 1 to 2 percent.” Health care associated infections
affect 5 percent of patients hospitalized in the country each year.3

Access to clinical trials
In addition to the IL-2 program, LVHN is the only
academic community hospital among eight major
medical institutions selected to take part in five earlyphase clinical trials conducted over the last year and a
half involving immunotherapy and stage 4 melanoma.
One phase 2 trial tested the sequential use of two
immunotherapy drugs: ipilimumab (Yervoy) and antiPD-1 (Nivolumab), both of which release the inhibition
on T-cell checkpoints to boost the immune system’s
response to melanoma cells.
“Three out of the four LVHN patients who qualified for
the clinical trial are now one year out and in complete
remission,” Nair says. “Overall, with these three
immunotherapy drugs — IL-2, ipilimumab and anti-PD1 — we have more hope than ever for durable
remissions and possible cures for patients with
advanced cases of melanoma,” Nair says.
To refer a patient for evaluation and potential inclusion
in a clinical trial at LVHN, call 610-402-CARE.
1. American Cancer Society.
2. “Ipilimumab and cancer immunotherapy: A new
hope for advanced stage melanoma.” M. Mansh. Yale
J Biol Med 2011 Dec; 84(4): 381-9.
3. Centers for Disease Control and Prevention.
Summer 2014

https://www.lvhn.org/for_referring_physicians/better_medicine/cancer/high_dose_il_2_among_available_melanoma_treatments[6/6/2018 1:19:23 PM]

Proper Staging for Chronic Kidney Disease Patients

Proper Staging for Chronic Kidney
Disease Patients
Roughly 10 percent of U.S. adults — about 20 million — have
chronic kidney disease (CKD).1 In its early stages, CKD is
silent, showing no symptoms. That’s why many patients aren’t
diagnosed until stages 5 or 6 of the six-stage illness, when they
emergently go on dialysis.
“That’s much too late,” says Lehigh Valley Health Network
(LVHN) nephrologist Nelson Kopyt, DO, who also is chief,
division of nephrology and medical director of the dialysis unit.
“Our goal is to get CKD patients diagnosed in stages 3 and 4 so
we can keep them out of the emergency department, delay the
need for dialysis and prevent acute myocardial infarctions or
strokes, while improving the quality of their care and their lives.”
Nelson Kopyt, DO
Nephrology

Data show that in the first year of dialysis, late-referral patients
have a 44 percent higher risk for mortality, especially from
cardiovascular events.2 Their treatment costs can range from $35,000-$50,000, while patients
identified sooner and properly prepared for dialysis require just $2,000 in medical services.
Patients with hypertension, diabetes mellitus, cardiovascular disease and/or a family history are at high
risk for CKD. Regular screening should include:
• Serum creatinine and estimated GFR (eGFR) laboratory studies
• Urinalysis to determine the presence of proteinuria
• Imaging studies (e.g., ultrasound)
Patients should be referred to a nephrologist for disease and risk factor co-management if they have an
eGFR of less than 50 or proteinuria of greater than 300 mg/day or heavy proteinuria with
albumin/creatinine ratio of greater than 1,000 mg/g.
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To refer a patient with CKD, call 610-402-CARE.
1. Centers for Disease Control and Prevention.
2. “Late nephrology referral and mortality among patients with end-stage renal disease: a propensity
score analysis.” Kazmi et al. Nephrol Dial Transplant. 2004; 19: 1808-14.
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Gamma Knife® Radiation for
Nonmalignant Conditions
While well known for treating metastatic brain lesions, Gamma
Knife radiation therapy also is a viable treatment for many
nonmalignant conditions. At Lehigh Valley Health Network
(LVHN), roughly one-third of the 150 patients treated with
Gamma Knife annually present with nonmalignant conditions. In
general, lesions of 3 centimeters or less are considered suitable
targets.
Here’s how Gamma Knife may help specific nonmalignant
conditions:
Trigeminal neuralgia (severe facial pain): Gamma Knife
intervention can be helpful if medications are unsuccessful
in alleviating the pain or if a patient complains of
unacceptable side effects. Median time to relief is about
one month, and approximately 70 percent of patients
maintain relief at two years.1

Alyson McIntosh, MD
Radiation oncology

Schwannomas (or acoustic neuromas, benign brain tumors
arising from the vestibular portion of the eighth cranial
nerve): Most schwannomas are detected when less than 3
centimeters. “In that case, using a noninvasive approach
avoids the morbidity of surgical intervention,” says LVHN
radiation oncologist Alyson McIntosh, MD, with Allentown
Radiation Oncology Associates and co-director of LVHN’s
Gamma Knife program. “And the 10-year local control rates
are 98 percent, with hearing preservation of 70 percent.”2
Meningiomas (benign tumors on the brain surface):
Gamma Knife stabilizes meningiomas located in a fragile
area, such as near the optic nerve. In addition, it is an
effective tool for patients who are not candidates for
surgery, the standard meningioma treatment. Gamma Knife

Stefano Camici, MD
Neurosurgery
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provides 90 percent local tumor control of meningiomas.3
Arteriovenous malformations (AVMs, abnormal bundles of arteries and veins): Patients with AVMs
carry a 2 to 4 percent risk for a bleed each year, causing stroke-like symptoms or possible death.
“Once we treat an AVM with Gamma Knife, the patient’s lifetime risk is reduced to less than 1
percent after we achieve obliteration,” McIntosh says. Gamma Knife yields a 90 percent AVM
obliteration rate, but it can take up to two years to achieve maximum obliteration as treated vessels
sclerose.4

Single, quick treatment
Because LVHN uses the latest-generation Perfexion™
Gamma Knife model, most indications require only a single
treatment, which usually takes one hour or less. “With
Perfexion, we are able to modulate the radiation dose in a
much superior way to the standard Gamma Knife,” says LVHN
neurosurgeon Stefano Camici, MD, with LVPG Neurosurgery.
“That allows us to spare adjacent structures much better than
previous versions.” This is a major benefit to patients,
especially when treating near sensitive tissues like the optic
nerve or brain stem.
To refer a patient for Gamma Knife surgery, call 610-402CARE.
1. “Trigeminal neuralgia pain relief after Gamma Knife
radiosurgery.” A.M. Baschnagel et al. Clin Neurol Neurosurg.
2014 Feb; 117:107-11.
2. “Long-term follow-up of acoustic schwannoma radiosurgery
with marginal tumor doses of 12 to 13 GY.” R. Chopra et al. Int
J Radiat Oncol Biol Phys. 2007 Jul; 68(3):845-51.
3. “Long-term outcomes after meningioma radiosurgery:
physician and patient perspectives.” D. Kondziolka et al. J
Neurosurg. 1999 Jul; 91(1):44-50.
4. Ibid.
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Better Management, Improved Access
for Patients With Movement Disorders
The prevalence of Parkinson’s disease, which affects at least
1.5 million Americans, is expected to double by 2040 as the
population ages.1 While there’s no cure for Parkinson’s, “the
earlier patients start treatment, the better they’re able to
manage the motor aspects of the disease,” says Lehigh Valley
Health Network (LVHN) neurologist Peter Barbour, MD, codirector of the movement disorders program at Lehigh
Neurology.
“Parkinson’s disease is the most common movement disorder
we treat,” says Barbour’s colleague, neurologist J. Gabriel Hou,
MD, PhD, who recently joined LVHN as program co-director to
help provide better access to patients with movement disorders.
“Of the estimated 1,500 patients with movement disorders in
our practice, approximately 800 have Parkinson’s disease,”
Barbour says.

Peter Barbour, MD
Neurology

Parkinson’s disease symptoms include resting tremor (trembling
in the hands, arms, legs, jaw and face), rigidity or stiffness of
the limbs and trunk, bradykinesia (slowness of movement) and
postural instability (or impaired balance and coordination).
LVHN manages Parkinson’s disease through three methods:
Dopaminergic medications that target dopamine
receptors and enzymes in the brain: “There are many
dopaminergic medications, and newer ones are coming
out,” Hou says. Some medications replace dopamine,
some mimic it, and some prolong the effect of dopamine by
interfering with metabolism.

J. Gabriel Hou, MD, PhD
Neurology
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Deep-brain stimulation: Lehigh Neurology provides
programming for neurostimulators, which are implanted in
the brain by neurosurgeons specially educated in this technique. A neurostimulator delivers
electrical impulses to targeted areas in the brain that control movement. “We can adjust the
frequency and pulse width as well as the strength of the electrical stimulation to make it work well
to reduce tremor and improve movement,” Hou says.
Physical therapy to help patients maintain function: Barbour and LVHN colleagues presented
a study at the 18th International Congress of Parkinson’s Disease and Movement Disorders in
June. Their research found that patients who used the Nintendo Wii had an improvement in step
length and speed, which correlates with fall risk. “These games can be tailored to a patient’s
rehabilitation program,” Barbour says.

In addition, patients can attend Get Up and Go group fitness classes at LVHN Fitness−Muhlenberg and
LVHN Fitness−Cedar Crest. The popular classes are specifically designed for patients dealing with the
physiological and psychological challenges of movement disorders. “It’s group therapy that combines
exercise with socialization and camaraderie,” says Barbour, who implemented the program more than
20 years ago.
In addition to Parkinson’s disease, LVHN manages patients with other movement disorders, such as
various tremor disorders, dystonia disorders, hemifacial spasm and blepharospasm, restless leg
syndrome, Huntington’s disease, Tourette’s syndrome and more. Some of these conditions may have
psychiatric aspects that can be equally as disabling, such as anxiety, depression, dementia and
psychosis. LVHN offers access to neuropsychology and neuropsychiatry services.
To refer a patient for neurological evaluation, call 610-402-CARE.
1. S. Res. 408: A resolution supporting the designation of April as “Parkinson’s Awareness Month,”
113th Congress, 2013-2015. govtrack.us/congress/bills/113/sres408/text.
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Collaboration, Innovation Lead
LVHN−Tilghman to High Marks in
Patient Satisfaction
The Center for Orthopedic Medicine at Lehigh Valley Health
Network (LVHN)−Tilghman is designed to provide a superior
experience for orthopedia patients. Early results indicate the
center is achieving that goal.
Since opening in February, the Center for Orthopedic
Medicine’s patient satisfaction scores on Press Ganey surveys
and Hospital Consumer Assessment of Healthcare Providers
and Systems (HCAHPS) evaluations place it in the highest
percentiles across a range of indices.
“We believe a location completely focused on orthopedic
surgery means a new, more efficient way of delivering care,”
says LVHN orthopedic surgeon Paul Pollice, MD, with OAA
Paul Pollice, MD
Orthopedic surgery
Orthopaedic Specialists. A collaborative effort with LVHN allows
Pollice and his colleagues at OAA Orthopaedic Specialists to
provide medical oversight of procedures done at the Center for Orthopedic Medicine. “Our goal is to be
proactive in identifying deficiencies and making meaningful changes in how we deliver care for this
clinical specialty.” The result, in addition to a high level of care, is a direct and personalized approach to
the patient experience.
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High scores on staff, facilities
Patient surveys indicate high satisfaction in nearly every area evaluated. In the HCAHPS survey,
LVHN−Tilghman scored in the 99th percentile for staff responsiveness, pain management, discharge
process and physician communication. In the Press Ganey analysis, respondents ranked LVHN−
Tilghman above the 95th percentile in:
Overall satisfaction with the hospital experience, staff and care provided
Physician skill, communication and friendliness
Nurse promptness, skill and attitude
Discharge communications andassistance
Operating room and recovery room satisfaction
Interactions with physical and occupational therapists
Among the highest ratings, scores for attention to patients’ personal concerns — including sensitivity to
privacy and convenience, inclusion in care decisions, pain management and attention to emotional
needs — ranged from 95 to 100 percent. Nearly 95 percent of inpatient respondents also were
extremely satisfied with the noise level and hospital atmosphere.
“Patients can have an incredible amount of anxiety leading up to surgery, which can be heightened or
quelled depending on their initial experience,” Pollice says. “We wanted to create an environment
where our patients feel calm, comfortable and safe from the moment they walk through ourthrough our
door.”
A patient-focused experience These scores are a testament to both the design of the new facility and
the quality of its clinicians. Physicians from OAA Orthopaedic Specialists and VSAS Orthopaedics
perform inpatient and outpatient surgeries at LVHN−Tilghman.
“We’ve brought together a group of extraordinary fellowship-trained specialists in every area of
orthopedics and sports medicine,” says Michael Pasquale, MD, chair of the department of surgery at
LVHN. “We’ve complemented them with fantastic nurses, anesthesiologists and ancillary staff, and our
patients see the difference.” Pollice says, “These scores are an order of magnitude higher than [those
of] other facilities I’ve worked with. It’s very gratifying."
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To refer a patient to an orthopedic surgeon at LVHN, call 610-402-CARE.
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A Comprehensive Approach to Sports
Medicine
Like many sports themselves, sports medicine is all about the
team. Coordination of treatment among a combination of
practitioners is paramount to optimizing care of the athlete.

Rob Palumbo, MD
Orthopedic surgery

When all these caregivers work not in isolation but in
collaboration, “it results in better outcomes,” says Lehigh Valley
Health Network (LVHN) orthopedic surgeon Rob Palumbo, MD,
with OAA Orthopaedic Specialists. “Through LVHN’s program,
we cover the spectrum of sports medicine care with a close-knit
group of specialists who are working together. If a physical
therapist isn’t happy with a patient’s progress, he can speak
with the physician. If the physician has a concern, he calls the
therapist. All of us are communicating with athletic trainers
working with schools and teams.”

A continuum of orthopedic care
LVHN sports medicine services span injury and illness,
prevention, evaluation, rehabilitation and performance training,
as well as consulting with primary care physicians to help make
treatment decisions. The program has specialists who address
all areas of orthopedic medicine, including surgeons who are
fellowship trained in every surgical subspecialty.

Neal Stansbury, MD
Orthopedic surgery

“Our specialists have accrued significant experience treating
more and different types of injuries,” says LVHN orthopedic
surgeon Neil Stansbury, MD, with VSAS Orthopaedics. “We
attend conferences regularly to ensure the surgeries and
treatments we offer are the latest and best available.”
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LVHN athletic trainers and rehabilitation therapists also have
extensive education in specialty fields. “We have 14
rehabilitation locations regionwide and board-certified
orthopedic specialists with fellowship training in multiple
orthopedic specialties,” says Jesse Schimmer, PT, DPT, LVHN
rehabilitation director. “And our patient-to-therapist ratio is much
lower than in most programs, typically two-to-one or one-toone.”

A passion for sports medicine

Jesse Schimmer, PT, DPT
Rehabilitation services

The broad expertise doesn’t end with subspecialty education.
LVHN orthopedic specialists have experience with virtually
every sport — both in treating injuries and participating
themselves.
Palumbo played college football, works with the National
Football League and the Lehigh Valley IronPigs, and provided
care for the U.S. Women’s National Soccer Team. Stansbury
holds a world record in cycling, is medical director of the Valley
Preferred Cycling Center, and treats competitive cyclists from
across the country. Other specialists with the program played
collegiate or professional hockey and baseball. Several are
world-class runners.
They all bring not just a love of orthopedic medicine but a
passion for sports. They also share a belief that sports medicine
functions best when clinicians closely coordinate across the
orthopedic care spectrum.

David Maxted, ATC
Athletic training

“Communication is our strength,” says LVHN certified athletic
trainer David Maxted, ATC. “Take an athlete with a concussion.
We know these athletes because we work with them every day, and we also know they may not be
forthcoming with information, because they are motivated to get back to competition. We talk almost
daily with the physicians and physical therapists to make sure that athlete is getting appropriate
treatment.”
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The combination of deep subspecialty expertise and collaboration among multiple service lines makes
a significant difference for patients.
“With traditional orthopedic medicine, the goal is to get the individual back to the point where he or she
can perform daily activities,” Palumbo says. “Our philosophy is to get athletes back to their pre-injured
state. If you’re playing basketball and tear a ligament, we’re not just trying to help you walk again. Our
goal is to get you back to playing, and playing well.”
To learn more about LVHN’s sports medicine program or to refer a patient, call 610-402-CARE.
Summer 2014
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Latest Laser Treatment Improves Scar
Appearance
Lehigh Valley Health Network’s (LVHN) Regional Burn Center
has launched a new scar treatment program to treat the scars
from burns as well as those from non-burn injuries.

Sigrid Blome-Eberwein, MD
Plastic surgery

“Any scar qualifies to be seen in our program,” says program
creator Sigrid Blome-Eberwein, MD, of LVPG Burn Surgery1210 Cedar Crest. The burn center is the only one in
Northeastern Pennsylvania verified by the American Burn
Association. Our practitioners provide about 5,000 outpatient
treatments every year on more than 1,500 new outpatients,
mainly those with burn injuries. About half of the program’s
patients present with non-burn-related scars. These can be due
to skin diseases or necrotizing infections, surgery, trauma, and
animal or insect bites — in short, any injury that leaves a scar.

In the program, physicians provide several interventional
approaches, including the latest in laser technology to remodel the look and feel of scars. Previously,
standard clinical practice for scars included anti-inflammatory or bleaching creams and pressure
garments. “After going through laser treatment, our burn patients do not need as much pressure
garment treatment as they used to,” Blome-Eberwein says. “And although we cannot make scars
disappear, we can make ugly, thick, red, itchy scars flatter and softer.”
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Leading-edge treatment
The Regional Burn Center offers patients the most advanced laser scar treatment available — the
fractional CO2 laser. “With this laser, we produce pinpoint injury to all layers of the skin,” says BlomeEberwein, whose background includes training in plastic surgery. She has done clinical research in
developing new laser techniques in combination with other treatments for the past 11 years and is now
conducting a trial at LVHN of laser therapy with and without anti-inflammatory cream. “The fractional
CO2 laser makes scar redness fade to white,” she says. It improves the thickness, texture and
tightness of the skin. The best outcomes have been in patients with surgical scars — “the scars
virtually melt away,” she says — but almost any scar that has some redness and hypertrophy responds
well.
Blome-Eberwein is the only doctor in the area applying this technology for scar treatment. Ideally,
treatment should begin in the two- to four-month range after wound healing, but she has successfully
treated scars that were six years old.

Additional options for patients
Microderm abrasion technology, the least invasive of the interventional scar protocols, is used mainly
for inclusion cysts and scar surface irregularities. It can be applied throughout the entire scar formation
cycle, which can take up to five years. Three to 10 treatments are needed.
LVHN physicians also apply nonablative laser therapy targeting the dermal skin layer. This treatment
can decrease redness and itchiness and prevent scars from thickening, leaving the remaining scar
softer. This treatment should begin one to two weeks after the wound is closed.
To refer a patient for laser scar treatment, call 610-402-CARE.
Summer 2014
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Physician-Hospital Alignment Will Help
Us Produce Value for Our Community
Dear physician colleague:
For the past 10-and-a-half years, I’ve had the privilege of
working alongside Ron Swinfard, MD, first while he served as
chief medical officer, then as president and chief executive
officer (CEO) of Lehigh Valley Health Network (LVHN). During
this period, we worked closely together while health care began
its evolution from fee-for-service to fee-for-value.
Now, as Dr. Swinfard has retired, I am privileged to serve as
LVHN’s acting president and CEO. Our Board of Trustees’
instructions to me are direct — the role is acting because they
want me and the entire organization to act. Top on the list will
be strategic endeavors that help LVHN produce value for our
community — that is, creating access to affordable and highquality care.

Brian Nester, DO, MBA
President and chief executive
officer Lehigh Valley Health
Network

Given the Institute of Medicine’s estimate that roughly 30
percent of health care spending is wasteful (IOM 2012), we
have the exciting opportunity to deliver appropriate and highquality care to more people at a lower cost by addressing shortcomings in care delivery. To implement
value production, we need a highly aligned ethical, financial and clinical compact between hospital and
physician providers. Together, we can efficiently and effectively address the needs of the populations
we serve.
The future of our health care economy will bring challenges. Administrative and billing functions will
become more complex. Competition for patients in the ambulatory setting will heat up as new care
outlets emerge. Physicians will need to continue to adapt to a business model that emphasizes access,
service, wellness and outcomes.
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We at LVHN are committed to facing these challenges with you, our physician colleagues. It’s why we
are assembling all the tools we need to produce value. We have inpatient facilities that are among the
nation’s best. We have 11 health centers and continue to build our outpatient assets. We already have
the AllSpire Health Partners consortium, which will help us gain economies of scale and other
corporate efficiencies. We have a partnership with Optum Labs to give us the “big data” we need to
effectively manage populations. And, we are implementing the Epic electronic medical record to
coordinate and track patient care across the continuum.
Producing value can only take place through an aligned commitment by hospitals and physicians. We
remain committed to you, and I ask for your continued collaboration with LVHN. Together we’ll continue
to find innovative ways to fulfill our mission — to heal, comfort and care for our community.
Sincerely,
Brian A. Nester, DO, MBA, FACOEP
President and chief executive officer Lehigh Valley Health Network
Summer 2014
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Firefly Imaging Aids Robotic Surgeons
Fluorescence, or Firefly imaging, is a game-changing tool that is
now being used in robotic gallbladder surgery at Lehigh Valley
Hospital (LVH)–Muhlenberg and LVH–Cedar Crest.
“The gallbladder and biliary tree are different for everyone,”
says Lehigh Valley Health Network (LVHN) board-certified
general surgeon Paul Cesanek, MD, with LVPG General and
Bariatric Surgery-1240 Cedar Crest. “Firefly helps us identify
anatomic variations we weren’t expecting, such as an extra duct
or one that’s closer to the structure we’re dividing than
anticipated. Being aware of them ahead of time can make
surgery safer and prevent complications for the patient.”
The leading-edge imaging technology involves injecting a
Paul Cesanek, MD
patient with indocyanine green dye, either pre-operatively or in
General surgery
Watch a video to learn more
the operating room. The dye is detected by the robot’s camera
about him.
and light source. The resulting illuminated tissue appears green
on the computer screen, similar to the night vision that’s used
by the U.S. military. Surgeons can contrast the operative view by toggling between the common white
light and the Firefly green light of the injected tissue.

Immediate reconstruction preferable
“There’s the potential to use this technology in multiple types of
surgery,” Cesanek says.
To refer a patient to a gallbladder specialist, call 610-402CARE.
Summer 2014
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Robotic Surgical Platform Reduces
Length of Stay
Since 2008, Lehigh Valley Health Network (LVHN) surgeons
have provided more than 3,500 patients with the potential for
better outcomes through the use of the da Vinci® Si HD
surgical robotics platform.
LVHN surgeons primarily use da Vinci within five oncology
service lines — gynecological oncology, thoracic oncology,
urologic oncology, colon-rectal surgery and hepatobiliary
surgery. The team has access to three da Vinci Si platforms,
two at Lehigh Valley Hospital (LVH)−Cedar Crest and one at
LVH−Muhlenberg.

Benefits to patients
Martin Martino, MD
Gynecologic oncology
Watch a video to learn more
about him.

“Since the robotics platform was adopted at LVHN, the rate of
open-incision laparotomies for endometrial cancer has declined
from 90 percent to 18 percent,” says LVHN gynecologic
oncologist Martin Martino, MD, medical director of LVHN’s
minimally invasive robotic surgery program. “Endometrial
cancer patients we treat with robotic surgery experience shorter operative times, less blood loss,
shorter length of stay, fewer transfusions and fewer complications compared to laparoscopic surgery.”
LVHN has performed about 400 robotic thoracic surgery procedures since 2011.
With robotics protocols, hospital length of stay (LOS) after some thoracic procedures at LVHN has
declined significantly. For esophagectomy, the average LOS at LVHN is five-and-a-half days,
compared with nine days for open procedures. In lung cancer robotic lobectomy, LOS is two days, as
opposed to six days for an open surgery -- getting patients back to their families more quickly.
LVHN data also show that robotic thoracic patients may experience a lower rate of postoperative
complications than is traditionally seen with open procedures.
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“LVHN’s minimally invasive surgical team also is the only one in Northeastern Pennsylvania to use the
robotics platform for single-site hysterectomy,” Martino says. “We are now able to offer women a
minimally invasive surgery with just a hidden scar in the navel.” With this procedure, women can be
back to work within two to three weeks, compared with six to eight for traditional surgery.
“Our team includes the only physicians in the region offering sentinel lymph mapping via infrared
imaging for patients with uterine cancer,” Martino says. In Firefly imaging, the surgeon injects an inert
molecule into the cervix, which travels to the sentinel nodes, considered the first nodes to which a
cancer may migrate. “We are able to remove that node and spare the rest,” Martino says. This provides
patients with a more minimally invasive approach with fewer complications, such as lymphedema and
cellulitis.

A multisurgeon, multidisciplinary team
“LVHN is home to one of the nation’s largest multidisciplinary robotic surgery oncology teams,” Martino
says. It includes pulmonologists, medical oncologists, radiation oncologists, social workers, geneticists
and nutritionists. The team also has its own staff of specially educated physician assistants and nurses.
“All patients are exposed to the team approach,” Martino says. Even if a patient does not personally
see each member of the team, the full team is working on each case.
To refer a patient for minimally invasive robotic surgery, call 610-402-CARE.
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Six years ago, Lehigh Valley Health Network (LVHN) partnered
with the newly formed Reproductive Medicine Associates of
Pennsylvania at Lehigh Valley (RMAPA) in Allentown to provide
reproductive endocrinology and infertility care to patients
throughout our region. RMAPA currently has in vitro fertilization
(IVF) birth rates per cycle of 68 percent, which is 27 percent
above the national average of 41 percent.1
“We offer an attentive atmosphere and access to leading-edge
technology and state-of-the-art research,” says reproductive
endocrinologist and obstetrician/gynecologist Wendy Schillings,
MD, FACOG, LVHN’s chief of reproductive endocrinology and
infertility (REI). “RMAPA offers nationally recognized,
exceptionally high-quality care for patients who suffer with
Wendy Schillings, MD
Hematology oncology
infertility, and RMAPA is immediately accessible to patients
right here in Allentown through its office on North Cedar Crest
Boulevard,” says obstetrician/ gynecologist Thomas Hutchinson, MD, chair, LVHN department of
obstetrics and gynecology.

‘ART’ and science of IVF
RMAPA uses the latest assisted reproductive technology (ART) and techniques, including:
Comprehensive chromosomal screening: This can identify blastocysts that are chromosomally
normal with unprecedented accuracy, increasing the likelihood of successful pregnancies. Developed
by Richard Scott Jr., MD, Schillings’ colleague at RMA of New Jersey and a partner in RMAPA, the
technology has been validated by rigorous clinical research.2
Blastocyst transfer: “We do only blastocyst transfers,” Schillings says. Embryos at this stage,
transferred on day six of culture, are more likely to result in successful pregnancies than those
transferred earlier.
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Single-embryo transfer: The primary risk of IVF has been high-order multiple pregnancies (triplets or
more). “This issue has been greatly minimized at RMAPA because we advise many patients to have a
single-embryo transfer and will transfer a maximum of only two embryos at a time,” she says. RMAPA’s
excellent success rate per embryo makes this approach feasible.3
Intensive follow-up: “Once our patients become pregnant, we follow them closely with blood work and
serial ultrasounds for eight weeks,” Schillings says. “After the eight-week pregnancy scan, we send
them back to their ob/gyn for further care.”
In addition to IVF, RMAPA also provides other reproductive endocrinology and infertility services,
including ovulation induction, intrauterine insemination and gamete preservation (freezing eggs/sperm).

When to make a referral
Referral to an infertility specialist is indicated for:
Women younger than age 35 who have been trying to conceive for one year
Women age 35 or older who have been trying to conceive for six months
RMAPA has a close working relationship and exclusive teaching partnership with LVHN. When surgery
is recommended, it is performed at Lehigh Valley Hospital.
After the initial patient consultation, Schillings sends a letter to the referring physician outlining the
recommended treatment strategy.
To refer a patient to RMAPA, call 610-402-CARE.
1. Thirty-one fresh IVF cycles performed in women less 35 years old in 2012 resulted in 68 percent
(21/31) of cycles resulting in live birth rates, as published by SART and CDC for Reproductive Medicine
Associates of Pennsylvania. The national average for 2012 is 41 percent per cycle, for the same age
group. A comparison of clinical cycle success rates may not be meaningful because patient medical
characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.
2. “Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer
significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial.”
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R.T. Scott Jr. et al. Fertil Steril. 2013 Sep; 100(3): 697-703.
3. “Single embryo transfer with comprehensive chromosome screening results in improved ongoing
pregnancy rates and decreased miscarriage rates.” E.J. Forman et al. Hum Reprod. 2012 Apr; 27(4):
1217-22.
Summer 2014

https://www.lvhn.org/for_referring_physicians/better_medicine/women_and_children/partnership_creates_strong_ivf_results[6/6/2018 1:31:33 PM]

Expert Care for Serious Childhood Infections

Expert Care for Serious
Childhood Infections
When she worked as a general pediatrician early in her career,
Tibisay Villalobos-Fry, MD, saw plenty of infectious disease
cases. “In regular pediatric practice, close to 90 percent of the
problems that are seen are infectious in nature,” she says. But
when a child presents with a difficult diagnosis, persistent fever
or unusual infection, those cases can become challenging.
Now Villalobos-Fry offers area pediatricians and family
medicine physicians subspecialty expertise as the region’s only
pediatric infectious disease specialist. Affiliated with Children’s
Hospital at Lehigh Valley Hospital, Villalobos-Fry is boardcertified in both pediatrics and pediatric infectious disease
medicine.
Tibisay Villalobos-Fry, MD
Villalobos-Fry addresses the gamut of infectious diseases in
Pediatric infectious disease
Watch a video to learn more
children and teens — from meningitis, tuberculosis and
about her.
complicated pneumonia to bone-andjoint infections and tickborne disease such as Lyme disease. “With Lyme, the
interpretation of clinical symptoms, exposure history and laboratory tests is not always straightforward,”
she says. Villalobos-Fry can help clarify the diagnosis. Through Lehigh Valley Health Network (LVHN)
she also has access to polymerase chain reaction technology that expedites diagnostic testing.

Fighting infection on all fronts
Pediatric infectious disease care at LVHN includes:
Inpatient care in the pediatric unit, pediatric intensive care unit and neonatal intensive care unit at
Children’s Hospital at Lehigh Valley Hospital
Coordination of IV antibiotic therapy in the hospital and at home
Outpatient care for patients who are referred to LVPG Pediatric Endocrinology-17th
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Street, including consultation, evaluation and treatment
A travel clinic offering immunizations and/or prophylactic treatments as well as travel precautions
for children preparing to travel abroad
An adoption clinic, offering full evaluation to rule out prior or current infections for children who are
being adopted from foreign countries
Villalobos-Fry also cares for children with fevers of unknown origin that have lasted for 10 days or
longer, and for HIV-exposed infants, who are followed up to age 18 months. Plus, as part of our
Children’s Hospital, Villalobos-Fry is able to collaborate and consult with other pediatric specialists and
pediatric surgeons as needed.

Closing the loop
As a former general pediatrician, Villalobos-Fry knows the importance of regular followup with referring
physicians. “I understand the primary care perspective,” she says. “When all of a child’s treatment
providers work together as a team, you get better outcomes and more satisfied families.”
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